Clinical trials
Phase 1 Immunoglobulin Light-chain Amyloidosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Terminated | 9 |
| Recruiting | 4 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 2 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| GlaxoSmithKline | 4 |
| Northwestern University | 3 |
| University of Tennessee | 3 |
| Attralus, Inc. | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Anhui Provincial Hospital | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Beijing Boren Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | 46 |
| Multiple Myeloma | 21 |
| Burkitt Lymphoma | 16 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 16 |
| Lymphoma, Follicular | 16 |
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Lymphoma, Large-Cell, Immunoblastic | 16 |
| Lymphoma, Mantle-Cell | 16 |
| Lymphoma, Non-Hodgkin | 16 |
| Neoplasms, Plasma Cell | 16 |
Trials
Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.